Jorge M. Gomez - May 9, 2022 Form 3 Insider Report for Moderna, Inc. (MRNA)

Role: Officer
Signature: /s/ Brian Sandstrom, As Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: May 9, 2022
Transactions value $: $0
Form type: 3
Date filed: 5/11/2022, 04:23 PM
Previous filing: Apr 11, 2022
Next filing: May 12, 2022

No securities are beneficially owned.

Remarks:

The reporting person was appointed Chief Financial Officer of the Issuer on May 9, 2022 but departed the Issuer on May 10, 2022 as reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on May 11, 2022.